Most Popular

1
N. Korea says it test-fired tactical ballistic missile with new guidance technology
2
[Weekender] Geeks have never been so chic in Korea
3
NewJeans members submit petitions over court injunction in Hybe-Ador conflict
4
S. Korea's exports of instant noodles surpass $100m for 1st time in April: data
5
[News Focus] Mystery deepens after hundreds of cat deaths in S. Korea

6
[Herald Interview] Byun Yo-han's 'unlikable' character is result of calculated acting
7
US Air Force blames power loss, weather for F-16 crash in S. Korea in May 2023
8
Samsung expected to introduce new Exynos processor in next Galaxy series
9
Ex-president Moon recalls in memoir NK leader voiced will not to use nukes
10
US expert says N. Korea might ignore Trump if he returns to White House

NewsletterSubscribe

Start your day with a roundup of key stories from The Korea Herald with news and comment on all that’s happening in Korea.

Samsung BioLogics issues W50b private placement bonds

By 최희석

Published : Aug. 12, 2016 - 16:11

- Link copied

[THE INVESTOR] Samsung BioLogics issued 50 billion won (US$45.31 million) worth of private placement bonds, local media reported on Aug. 12.

Citing financial industry sources, the news reports stated that the company issued 1-year private placement bonds. This is the third time the company has issued bonds this year. In January and March, the company had issued bonds with a combined value of 120 billion won.

The company said that the bonds were issued to raise money to cover the cost of building its third plant. The company is the world’s third largest biologics contract manufacturer by capacity.

By Choi He-suk (cheesuk@heraldcorp.com)

Samsung BioLogics issues W50b private placement bonds

More from Headlines